StockData
ATECNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Alphatec Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$10.41−0.05 (-0.48%)

Close on Oct 19, 2026

Market cap
$1.63B
P/E (TTM)
–
Dividend yield
–

Earnings

Next report expected Oct 29, 2026, after market close (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Aug 4, 2026After market close$214.00M$-0.16$0.07
Q1 FY2026
Ended Mar 31, 2026
May 5, 2026After market close–––
Q4 FY2025
Ended Dec 31, 2025
Jan 12, 2026Before market open–––
Q3 FY2025
Ended Sep 30, 2025
Oct 30, 2025After market close$197.00M$-0.19$0.03
Q2 FY2025
Ended Jun 30, 2025
Jul 31, 2025After market close$186.00M$-0.27$0.02
Q1 FY2025
Ended Mar 31, 2025
May 1, 2025After market close$169.00M$-0.35–
Q4 FY2024
Ended Dec 31, 2024
Jan 13, 2025Before market open–––
Q3 FY2024
Ended Sep 30, 2024
Oct 30, 2024After market close–––
Q2 FY2024
Ended Jun 30, 2024
Jul 31, 2024After market close–––
Q1 FY2024
Ended Mar 31, 2024
May 7, 2024After market close–––
Q4 FY2023
Ended Dec 31, 2023
Feb 27, 2024After market close–––

Company guidance

Outlook given with results on Aug 4, 2026, compared with the previous outlook

MeasurePeriodGuidancevs. prior
adjusted EBITDAnon-GAAPfiscal year 2026$140.00MRaised
free cash flownon-GAAPfiscal year 2026$20.00MMaintained
total revenuefiscal year 2026$882.00MRaised
surgical revenue growththe year17% growthRaised
total revenue growththe year15% growthLowered
EOS revenuefiscal year 2026$77.00MLowered
surgical revenuefiscal year 2026$805.00MLowered

Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.

Press releases

Announcements Alphatec filed with the SEC